CODX
NASD Co-Diagnostics, Inc.$0.6473 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.6473, $0.0527 below the day’s high of $0.7000
- YTD change
- -87.20%
- vs 20-day SMA
- -36.92%
- vs 200-day SMA
- -73.15%
Price ranges
Price & Performance
-1.02 (-61.24%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 99.9% away from all-time highs of $929.7000
- CODX is down 87% since the beginning of the year
- CODX is down 94% over the past 12 months
- CODX is down 36% over the past 1 month
- 5% of all CODX investors are betting against CODX
CODX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +87.2%.
- Previous minute
- +$0.0000
- Last hour
- -$0.0002
- Last 5 days
- -48.22%
- vs 8-day SMA
- -29.30%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.